• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Sunday, September 6, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News

Using herpes drugs to slow down Alzheimer’s disease could become reality

Bioengineer by Bioengineer
December 13, 2016
in Science News
Reading Time: 1 min read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

(Umea University) The first clinical study to investigate if herpes virus drugs can have an effect on fundamental Alzheimer's disease processes has been launched at Umeå University in Sweden. The research group has previously demonstrated a correlation between herpes virus infection and an increased risk of Alzheimer's disease.

############

Story Source: Materials provided by Scienmag

Share12Tweet8Share2ShareShareShare2

Related Posts

New lethal mouse model of Coxsackievirus B1 enables antiviral drug testing

New lethal mouse model of Coxsackievirus B1 enables antiviral drug testing

September 6, 2026
New field-testing methods reveal stiffness of asphalt pavement layers

New field-testing methods reveal stiffness of asphalt pavement layers

September 6, 2026

Lynch Syndrome Linked to Metastatic Nonfunctional Pancreatic Neuroendocrine Tumor

September 6, 2026

METTL3/YTHDF1-driven SURF6 boosts prostate cancer stemness through CDK4

September 6, 2026
Please login to join discussion

POPULAR NEWS

  • New lethal mouse model of Coxsackievirus B1 enables antiviral drug testing

    29 shares
    Share 12 Tweet 7
  • New field-testing methods reveal stiffness of asphalt pavement layers

    29 shares
    Share 12 Tweet 7
  • Lynch Syndrome Linked to Metastatic Nonfunctional Pancreatic Neuroendocrine Tumor

    29 shares
    Share 12 Tweet 7
  • METTL3/YTHDF1-driven SURF6 boosts prostate cancer stemness through CDK4

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

New lethal mouse model of Coxsackievirus B1 enables antiviral drug testing

New field-testing methods reveal stiffness of asphalt pavement layers

Lynch Syndrome Linked to Metastatic Nonfunctional Pancreatic Neuroendocrine Tumor

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 85 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.